Healthcare ChatGPT Ads compliance India — hub
Six regulatory regimes govern a single healthcare ChatGPT Ad in India, and any one of them can pause a live campaign. This hub is the anchor reference ICG uses before every push — how the rules read, how they apply differently inside a conversational ad than inside a static banner, and the checklist that keeps a campaign clean end to end.
Six regimes, paraphrased and sourced
Healthcare advertising in India was never governed by one law, and ChatGPT Ads inherit that fragmentation whole. NMC Section 6 of the National Medical Commission's Code of Ethics Regulations, 2002 (carried forward under the NMC Act framework), restricts a registered medical practitioner from soliciting patients through advertisement, publishing result or success-rate claims, or claiming superiority over another practitioner or facility. It was written for print and signage; it applies without modification to a sponsored response inside ChatGPT because the underlying act — a doctor or clinic advertising for patients — hasn't changed, only the surface has.
ASCI Chapter III of the Advertising Standards Council of India's Code for Self-Regulation covers healthcare and wellness advertising specifically, prohibiting claims that exploit fear, promise unrealistic outcomes, or use before/after imagery without substantiation. ASCI's complaint-driven review process doesn't care what platform carried the ad — a ChatGPT sponsored response is squarely "advertising" under its definition.
DPDP 2023, the Digital Personal Data Protection Act, governs any point where the ad or its follow-up exchange collects a name, phone number, or health-adjacent detail — consent must be specific, informed, and revocable, and the lawful-purpose basis has to be documented before the data moves anywhere near a CRM. The ART (Regulation) Act 2021 adds a fertility-specific overlay banning guaranteed-outcome language and unregistered-clinic promotion. DCGI/UCPMP 2024 governs anything pharma-adjacent — drug efficacy claims, off-label promotion, and practitioner-directed incentive language are all restricted. And AYUSH advertising rules cap what an ayurveda, yoga, unani, siddha, or homeopathy brand can claim about curing or treating a named condition, with a specific prohibition on claims for a defined list of diseases under the Drugs and Magic Remedies Act read alongside AYUSH ministry guidance. Six regimes, one ad unit, zero tolerance for treating any of them as optional because the surface is new.
Why a ChatGPT Ad is a different compliance object than a Google or Meta ad
A Google Search ad is a fixed 30-character headline and 90-character description that a reviewer checks once and it stays checked — the words on the page never change after approval. A Meta ad is a static image or video with a caption, same logic. A ChatGPT Ad is neither. It's a sponsored response woven into a live, generative conversation, and the assistant retains latitude to paraphrase, summarise, or expand on the underlying claim when the user asks a follow-up. That means the compliance unit isn't the submitted ad copy — it's the claim underneath the copy, because the claim is what survives paraphrase.
Concretely: an approved ChatGPT Ad headline that says "IVF care backed by 20 years of clinical experience" is compliant on its face. But if a user follows up with "how successful is their IVF programme," the assistant may synthesise an answer from whatever data the advertiser has surfaced elsewhere — a landing page stat, a schema markup field, a review snippet — and produce a success-rate claim the original ad never stated outright. NMC Section 6 and ASCI Chapter III both attach to that synthesised answer just as much as to the original headline, because the user experiences it as one continuous claim from the brand, not two separate assets from two separate review passes.
This is the single biggest mental shift a team coming from Google or Meta needs to make. On a static platform, compliance review happens once, at submission. On ChatGPT Ads, compliance review has to account for every reasonable follow-up question a user might ask, because the model will answer it using whatever source material the advertiser has made available — landing page copy, structured data, even prior conversation turns from other users if the model has learned general patterns about the brand. A claim that's clean in isolation but ambiguous in context is not actually clean; it's a claim waiting for the wrong follow-up question.
Attribution compounds the risk rather than reducing it. Because ChatGPT Ads credit a lead on conversation-completion rather than click, a non-compliant paraphrase that happens to convert well doesn't just risk a takedown — it risks a takedown after the campaign has already scaled spend against that exact conversational pattern, because completion-based attribution rewards whatever gets the user to finish the journey fastest, compliant or not. ICG's review therefore treats the source claim, the landing page, and the structured data feeding the model as one compliance surface, not three separate ones reviewed on different days.
What actually goes wrong, in anonymised real campaigns
The failure pattern ICG sees most often when a healthcare brand runs its first ChatGPT Ads batch is a straight copy-paste of Meta ad copy into the new channel without a rewrite pass. An anonymised aesthetic-clinic client's Meta campaign used the line "94% patient satisfaction, book your consult today" — technically softened as a satisfaction score rather than a clinical outcome, but still an unsubstantiated number with no named source. Carried into a ChatGPT Ad unchanged, the same line surfaced inside a conversational answer to "is this clinic good," where the assistant's neutral tone made the number read as a verified fact rather than marketing copy. ASCI Chapter III treats that presentation as materially misleading regardless of intent. The fix was removing the number entirely and replacing it with a specific, verifiable claim — years in operation, procedure volume, or a named accreditation — that doesn't require substantiation ICG can't produce on demand.
A second recurring pattern involves an anonymised fertility client whose ad copy named a specific consultant with "India's top IVF specialist" language pulled from an old print advertorial. NMC Section 6's bar on superiority claims made this an immediate rewrite regardless of platform, but the ART Act 2021 overlay made it a two-violation issue — the same line also implied an outcome guarantee that fertility advertising specifically prohibits. The rewrite kept the consultant's name and registration number (which is allowed and in fact strengthens trust signal) but dropped every comparative and outcome adjective, replacing them with factual tenure and case-volume language.
A third pattern is DPDP-specific and easy to miss: an anonymised diagnostics-chain client's ChatGPT Ad prompted users toward a "quick symptom check" before redirecting to a booking page — a well-intentioned UX pattern borrowed from a chatbot flow, but one that collects health-adjacent input (symptoms) inside the ad experience itself, before the user ever reaches a page with a privacy notice or consent checkbox. DPDP 2023 treats that exchange as a personal-data collection event the moment it happens, not the moment it's stored, so the fix moved consent language into the ad-adjacent flow itself rather than relying on the landing page to catch it after the fact.
A fourth pattern, specific to AYUSH-adjacent brands, is naming a treatable condition directly in ad copy — "ayurvedic treatment for diabetes" — where the Drugs and Magic Remedies Act restricts advertising cures for a defined disease list regardless of the platform. The consistent fix across all four patterns is the same: strip the claim to what's independently verifiable, keep specificity (names, registration numbers, tenure, accreditation) because specificity builds trust without creating regulatory exposure, and remove anything that functions as an outcome promise, a comparison, or a disease-cure claim.
Worked examples, before and after
"Best cardiology hospital in Delhi NCR — 98% success rate on bypass surgery. Book now."
"NABH-accredited cardiac care in Delhi NCR, 15+ years and 12,000+ procedures performed. Consult our cardiology team this week."
The rewrite drops "best" (an NMC/ASCI superiority claim) and "98% success rate" (an unsubstantiated outcome claim) and replaces both with facts that are independently checkable — accreditation status, years operating, procedure volume — which carry equal or greater persuasive weight without regulatory exposure. This pattern generalises: replace every superlative and every outcome percentage with a specific, sourced, checkable fact.
"Guaranteed pregnancy in 3 IVF cycles or your money back — India's leading fertility centre."
"ART Act-registered fertility centre. Dr. [Name], Reg. No. [XXXXX], 18 years in reproductive medicine. Speak with our team about your options."
Guarantee language is removed outright — the ART Act treats any pregnancy-outcome guarantee as a clear violation regardless of phrasing, and "money back" framing makes it worse by turning a medical outcome into a commercial promise. The clean version leans on registration and tenure instead, both of which a regulator can verify in seconds and neither of which a competitor can contest.
"Reverse your diabetes naturally with our ayurvedic programme — trusted by thousands."
"Ayurvedic wellness programme for metabolic health, developed with AYUSH-registered practitioners. Learn about our approach."
"Reverse your diabetes" is a disease-cure claim restricted under the Drugs and Magic Remedies Act; "trusted by thousands" is an unverifiable social-proof claim. The rewrite reframes around wellness and practitioner credentials — a legally sound position that still communicates expertise and trust without naming a cure for a restricted condition.
Pricing
Retainers from ₹20,000/month · Custom-scoped per engagement.
The realistic sequence of events, not the worst-case story
An audit or complaint against a healthcare ChatGPT Ad typically starts from one of three sources: a competitor or patient complaint to ASCI, a routine review by OpenAI's ad partner network flagging a claim pattern, or an NMC/state medical council inquiry triggered by a practitioner-conduct complaint. None of these move instantly — ASCI's process runs on a complaint-review-response cycle typically resolved in weeks, and platform-side reviews on a new ad format tend to pause the specific ad unit pending clarification rather than suspending the advertiser's whole account outright.
The immediate commercial consequence is usually a paused campaign and a gap in attribution data, not a fine — ASCI's primary remedy is claim withdrawal or modification, and NMC's exposure attaches to the named practitioner's professional conduct rather than the advertising agency running the campaign. The larger cost, in ICG's experience, is time: a paused campaign during the 90-180 day first-mover window on a new ad surface loses more in forgone conversation-history and completion-rate data than most regulators' formal penalties amount to, because that data advantage is what lets a healthy campaign keep outbidding competitors as the auction matures.
ICG's response protocol on a flagged claim is documented and fast: the review trail from the pre-push checklist is produced immediately, the specific claim is withdrawn or rewritten within 24-48 hours, and the rest of the batch — which went through the same checklist — continues running unless the platform specifically requests a broader pause. Clients on a Scale or Enterprise engagement get a dedicated compliance point of contact for exactly this scenario; Starter and Growth clients route through the same review-trail process on request. The goal of the checklist isn't zero risk, which doesn't exist in a regulatory environment with six overlapping regimes — it's making sure that when a claim is questioned, the answer is a documented review trail produced in hours, not a scramble to reconstruct what was approved and why.
Compliance-clean ChatGPT Ads, built by a healthcare-only team
ICG's checklist runs on every batch, every tier, before a single rupee of media spend goes live. Talk to us about your specialty's specific overlay.
